Genetic Technologies Limited's Comment on Supply Chain
In the 2024 financial year, the company's raw materials and changes in inventory costs decreased by A$574,955 (13%), from A$4,335,265 to A$3,760,310, reflecting a decline in product revenue from EasyDNA. Commissions decreased to A$216,414, related to agency sales commissions for EasyDNA and AffinityDNA. Advertising expenses for EasyDNA and AffinityDNA also declined, notably in pay-per-click advertising costs. The company’s suppliers include AffinityDNA and EasyDNA.
Genetic Technologies Limited's Comment on Supply Chain
In the 2024 financial year, the company's raw materials and changes in inventory costs decreased by A$574,955 (13%), from A$4,335,265 to A$3,760,310, reflecting a decline in product revenue from EasyDNA. Commissions decreased to A$216,414, related to agency sales commissions for EasyDNA and AffinityDNA. Advertising expenses for EasyDNA and AffinityDNA also declined, notably in pay-per-click advertising costs. The company’s suppliers include AffinityDNA and EasyDNA.
Sources:
Genetic Technologies Limited's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Genetic Technologies Limited’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
